Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$40.26 - $57.37 $530,586 - $756,079
-13,179 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$54.88 - $79.29 $191,695 - $276,959
-3,493 Reduced 20.95%
13,179 $749,000
Q1 2021

May 10, 2021

BUY
$70.65 - $96.76 $1.18 Million - $1.61 Million
16,672 New
16,672 $1.25 Million
Q4 2020

Feb 10, 2021

SELL
$58.41 - $89.06 $1.75 Million - $2.67 Million
-30,000 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$26.15 - $77.24 $125,520 - $370,752
4,800 Added 19.05%
30,000 $862,000
Q4 2019

Feb 06, 2020

BUY
$60.18 - $154.77 $788,358 - $2.03 Million
13,100 Added 108.26%
25,200 $1.82 Million
Q3 2019

Nov 08, 2019

SELL
$140.29 - $189.96 $757,566 - $1.03 Million
-5,400 Reduced 30.86%
12,100 $1.7 Million
Q2 2019

Aug 12, 2019

SELL
$157.85 - $183.09 $315,700 - $366,180
-2,000 Reduced 10.26%
17,500 $3.2 Million
Q1 2019

May 10, 2019

SELL
$89.33 - $163.65 $1.23 Million - $2.26 Million
-13,800 Reduced 41.44%
19,500 $3.1 Million
Q4 2018

Feb 08, 2019

BUY
$81.94 - $139.71 $1.44 Million - $2.46 Million
17,600 Added 112.1%
33,300 $3.19 Million
Q1 2018

May 15, 2018

SELL
$152.15 - $192.33 $6.03 Million - $7.62 Million
-39,600 Reduced 71.61%
15,700 $2.53 Million
Q4 2017

Feb 14, 2018

SELL
$60.72 - $167.34 $1.43 Million - $3.95 Million
-23,600 Reduced 29.91%
55,300 $9.11 Million
Q2 2017

Aug 07, 2017

BUY
N/A
78,900
78,900 $6.28 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.